Subscribe

What are you looking for?

Main Menu

明報新聞網

來凱醫藥簽獨家許可協議 曾升逾8%

Future Wealths
Future Wealths
12 11 月, 2025
One Min Read
3 Views
0 Comments
來凱醫藥－Ｂ(2105)公布，與齊魯製藥就LAE002(AFURESERTIB)簽訂中國地區的獨家許可協議，公司有權獲得最高5.3億元人民幣里程碑付款。股價曾升逾8%。

原文: https://finance.mingpao.com/fin/instantf/20251112/1762911905775/%e4%be%86%e5%87%b1%e9%86%ab%e8%97%a5%e7%b0%bd%e7%8d%a8%e5%ae%b6%e8%a8%b1%e5%8f%af%e5%8d%94%e8%ad%b0-%e6%9b%be%e5%8d%87%e9%80%be8

Last Update: 12 11 月, 2025

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept